Opinion

How do different data preprocessing techniques affect performance of machine learning models on prediction tasks?

Artificial intelligence (AI) and machine learning (ML) systems have become central to modern data-driven decision-making. They are now widely applied in fields as diverse as healthcare, finance, ...

Self-improvement or self-deception? The hidden risk of AI building itself

The more we rely on AI, without oversight or validation, the greater our exposure is to making critical decisions based on ...

MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI’s 2026 Performance

SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal ...
International Monetary Fund

Alternative Data and Monetary Policy

In the spring of 2020, the Federal Reserve faced a challenge: The COVID-19 pandemic was upending daily life with shutdowns, social distancing, and heightened uncertainty, but the traditional economic ...
Business Insider

Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...
The Motley Fool

This $4 Stock Could Be Your Ticket to Millionaire Status

It comes as no surprise that artificial intelligence is at the heart of the opportunity. This application of AI, in fact, is arguably one of the best uses of this young technology. The chief stumbling ...
Forbes

How Recursive AI Agents Can Help Turn Real-Time Data Into Smarter, Self-Improving Operations

Imre Szenttornyay, CEO of Cielo IT LLC, empowers business owners to scale their operations profitably with AI-powered SmartSigns technology. When you manage a network of retail or franchise locations, ...
MarketWatch

Structure Therapeutics details positive trial data for a weight-loss pill, and the stock rockets

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...
Reuters

Recursion Pharma's AI-powered therapy reduces polyp growth in a rare disease trial

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
FierceBiotech

Wave, Structure stocks double on obesity data readouts

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...
The Bakersfield Californian

Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial ...

Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...